Statement from American Society of Hematology President David A. Williams, MD, on Passage of Continuing Resolution
Oct 02, 2015
As the world’s largest professional society
concerned with the causes and treatment of blood disorders, the American
Society of Hematology represents more than 14,000 members, many of whom depend
on funding from the National Institutes of Health to conduct cutting-edge
research that results in better treatments and cures for millions of patients
with blood diseases and cancer worldwide.
Study: Brentuximab Vedotin Effective, Safe in Elderly Hodgkin Lymphoma Patients Who Cannot Tolerate Standard Chemotherapy
Sep 21, 2015
A study published online in Blood, the Journal of the American Society of Hematology, reports that brentuximab vedotin is an effective and safe first course of treatment for older Hodgkin lymphoma patients unfit for chemotherapy.
ASH Meeting on Hematologic Malignancies Provides Important Clinical Updates
Sep 15, 2015
The American Society of Hematology (ASH), the world’s largest professional organization dedicated to the causes and treatments of blood disorders, will bring together practitioners from around the world for the ASH Meeting on Hematologic Malignancies, September 17-19 in Chicago. The meeting will feature the top experts in the field, who will share their strategies for caring for patients with hematologic malignancies.